Additional information
| Manufacturer |
Merck KGaA |
|---|---|
| Function |
DC Excipient, Direct compression |
| Dosage Form |
ODT, orally disintegrating tablets, Tablets |
Back to shop
Parteck® ODT
€0.00
Description
Parteck® ODT excipient is part of the Parteck® range of functional excipients developed specifically for solid dose applications. It is a directly compressible excipient designed for orally disintegrating tablets and provides rapid disintegration and exceptional strength as well as a pleasant taste and mouthfeel. As Emprove® Essential excipient, it is a high quality pharmaceutical excipient, offered with extensive documentation facilitating compliance, full supply chain transparency and risk mitigation.
Parteck® ODT – Directly Compressible Excipient for ODTs
Orally disintegrating tablets (ODTs) are preferred for their convenience and speed. By providing fast-acting medication, ODTs allow manufacturers to add value to existing compounds and – important for competitive standing – extend product life cycles. With the ODT market growing at around 20% per year, the opportunities are considerable. Merck’s Parteck® ODT gives formulators the opportunity to produce top quality, rapid acting tablets more cost effectively than ever.
Benefits of Parteck® ODT:
- Robust tablets at low compression forces
- Rapid disintegration and dissolution
- No license payments
- High dilution potential – up to 50% load of your active pharmaceutical ingredient (API)
- Tablets with Parteck® ODT are suitable for conventional coating
- Emprove® documentation and regulatory support